MiNK Therapeutics, Inc.

INKT · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$11-$22-$28-$30
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$2$4$3$2
Change in WC$0$3$9$4
Other Non-Cash-$1-$0-$3$12
Operating Cash Flow-$10-$16-$19-$13
Investing Activities
PP&E Inv.$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0-$0-$0-$0
Financing Activities
Debt Repay.$5$0$0$9
Stock Issued$6$0$0$40
Stock Repurch.$0-$0-$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$11-$0-$0$49
Forex Effect-$0-$0$0$0
Net Chg. in Cash$1-$16-$19$36
Supplemental Information
Beg. Cash$3$20$39$3
End Cash$5$3$20$39
Free Cash Flow-$10-$16-$19-$13